Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets

Chest

Volumn 110, Issue 4, 1996, Pages 1041-1047

  Böttiger, Bernd W ^a   Motsch, Johann ^a   Dörsam, Joachim ^a   Mieck, Ulf ^a   Gries, André ^a   Weimann, Jörg ^a   Martin, Eike ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

nitric oxide inhalation; pulmonary arterial hypertension; pulmonary embolism

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; MICROEMBOLISM; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0029979727     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.1041     Document Type: Article

References (37)

1. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17:259-70
2. Soloff A, Rodman T. Acute pulmonary embolism: II. Clinical. Am Heart J 1967; 74:829-47
3. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108:978-81
4. McIntyre KM, Sasahara AA. The hemodynamic reponse to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971; 28:288-94
5. Böttiger BW, Bach A, Böhrer H, et al. Acute pulmonary embolism: clinical, pathophysiological, diagnostic, and therapeutic aspects. Anaesthesist 1993; 42:55-73
6. Goldhaber SZ. Thrombolysis for pulmonary embolism. Prog Cardiovasc Dis 1991; 34:113-34
7. Schmid C, Zietlow S, Wagner TOF, et al. Fulminant pulmonary embolism: symptoms, diagnostics, operative technique, and results. Ann Thorac Surg 1991; 52:1102-07
8. Ducas J, Girling L, Schick U, et al. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism. Circulation 1986; 73:1050-57
9. Tajimi K, Tanaka H, Kasai T, et al. Selective pulmonary vasodilatory effect of ZSY-27 in dogs with pulmonary hypertension due to pulmonary embolism. Crit Care Med 1989; 17:163-65
10. Calvin JE. Acute right heart failure: pathophysiology, recognition, and pharmacological management. J Cardiothorac Vasc Anesth 1991; 5:507-13
11. Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87-95
12. Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83:2038-47
13. Girard C, Lehot JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77:880-83
14. Miller OI, Celermajer DS, Deanfield JE, et al. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after oprations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108:487-94
15. Roberts JD, Polaner DM, Lang P, et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-19
16. Rossaint H, Falke KJ, Lopez F, et al. Inhaled nitric oxide in adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
17. Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995; 107:1107-15
18. National Institutes of Health. Guide for the care and use of laboratory animals (NIH publication No. 85-23). Washington, DC: NIH, 1985
19. 2 formation during application of inhaled nitrogen monoxide (NO). Anasthesiol Intensivmed Notfallmed Schmerzther 1994; 29:157-62
20. Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 1984; 60:132-35
21. Martin U, Sponer G, Strein K. Rapid reversid of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022. J Cardiovasc Pharmacol 1993; 21:455-61
22. Prewitt HM, Shiffman F, Greenberg D, et al. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension: effect of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow relationship. Circulation 1989; 79:929-38
23. 1 in the adult respiratory distress syndrome: benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis 1989; 139:106-10
24. 1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 1989; 70:601-06
25. Puckett CL, Gervin AS, Rhodes GR, et al. Role of platelets and serotonin in acute massive pulmonary embolism. Surg Gynecol Obstet 1973; 137:618-22
26. Utsunomiya T, Krausz MM, Levine D, et al. Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest 1982; 70:361-68
27. Gerlach H, Rossaint R, Puppert D, et al. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:499-502
28. Schürmann M, Stiegler H, Riel KA, et al. Lung embolisms in a surgical patient sample: a retrospective study over 9 years. Chirurg 1992; 613:811-16
29. Molloy WD, Lee KY, Girling L, et al. Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 1984; 130:870-74
30. Ozier Y, Dubourg O, Farcot JC, et al. Circulatory failure in acute pulmonary embolism. Intensive Care Med 1984; 10:91-7
31. Hirsch LJ, Rooney MW, Wat SS, et al. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991; 100:796-801
32. 1 in primary pulmonary hypertension. Crit Care Med 1986; 14:72-3
33. Kasper W, Geibel A, Tiede N, et al. Patent foramen ovale in patients with haemodynamically significant pulmonary embolism. Lancet 1992; 340:561-64
34. Estagnasié P, Le Bourdellès H, Mier L, et A. Use of inhaled nitric oxide to reverse flow through a patent foramen ovale during pulmonary embolism. Ann Intern Med 1994; 120:757-59
35. Högman M, Frostell C, Arnberg H, et al. Bleeding time prolongation and NO inhalation. Lancet 1993; 341:1664-65
36. Motsch J, Gries A, Bode C, et al. Effect of inhaled nitric oxide on platelet function in micropigs [abstract]. Anesth Analg 1995; 80:S330
37. Samama CM, Diaby M, Fellahi JL, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 1995; 83:56-65